Firm wins landmark en banc patent decision in Federal Circuit

In a highly anticipated decision, the Federal Circuit, sitting en banc, significantly restricted the scope of the patent law's "inequitable conduct" doctrine. The decision was a victory not only for MoloLamken's client, but also for a large segment of the patent bar that had long sought changes to the doctrine. Read more:

Happy with Therasense ruling? Thank GW prof John Whealan

To read the full opinion, please click here.